Aggressive Natural Killer Cell Leukemia: A Brief Overview of Its Genomic Landscape, Histological Features, and Current Management

Aggressive natural killer-cell leukemia (ANKL) is a rare hematological malignancy characterized by the abnormal proliferation of natural killer (NK) cells. There are currently no therapies approved by the US Food and Drug Administration (FDA) for the treatment of ANKL, but advancements in genomics a...

Descripción completa

Detalles Bibliográficos
Autores principales: Sumbly, Vikram, Vest, Mallorie, Landry, Ian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956279/
https://www.ncbi.nlm.nih.gov/pubmed/35345687
http://dx.doi.org/10.7759/cureus.22537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956279/
https://www.ncbi.nlm.nih.gov/pubmed/35345687
http://dx.doi.org/10.7759/cureus.22537

Ejemplares similares